Parker Albert P
Insider CIK 1750079 · ZYNE Chief Legal Officer · OCX Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZYNE Zynerba Pharmaceuticals, I | D To issuer deriv | 2023-10-10 | 2023-10-11 | 200,000 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | U Tender | 2023-10-10 | 2023-10-11 | 33,685 | — | $0 | 193,333 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | U Tender | 2023-10-10 | 2023-10-11 | 278,333 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-10-10 | 2023-10-11 | 85,000 | — | $0 | 278,333 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2023-02-15 | 2023-02-17 | 3,173 | $0.54 | $1.7K | 227,018 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | F Tax w/h | 2023-02-08 | 2023-02-09 | 5,463 | $0.60 | $3.3K | 230,191 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-02-07 | 2023-02-09 | 18,864 | — | $0 | 235,654 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | F Tax w/h | 2023-02-01 | 2023-02-02 | 5,841 | $0.60 | $3.5K | 216,790 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-01-31 | 2023-02-02 | 17,631 | — | $0 | 222,631 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-01-24 | 2023-01-25 | 170,000 | — | $0 | 205,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2022-02-14 | 2022-02-15 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2022-02-14 | 2022-02-15 | 35,000 | — | $0 | 35,000 | SEC↗ |
| OCX OncoCyte Corp | A Award | 2020-12-11 | 2020-12-15 | 5,586 | — | $0 | 10,586 | SEC↗ |
| OCX OncoCyte Corp | P Buy | 2020-08-03 | 2020-08-05 | 5,000 | $1.33 | $6.7K | 5,000 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2020-02-10 | 2020-02-12 | 204,000 | — | $0 | 204,000 | SEC↗ |
| OCX OncoCyte Corp | A Award deriv | 2019-03-14 | 2019-03-18 | 200,000 | — | $0 | 200,000 | SEC↗ |